MindWalk Launches $2.3 Million Stock Buyback Program

MindWalk Holdings Corp. (NASDAQ: HYFT), a bio-native artificial intelligence company, has announced that its board of directors has authorized a share repurchase program under which the company may repurchase up to 2.3 million of its common shares, without par value, over a 12-month period beginning October 15, 2025, and ending no later than October 15, 2026. This represents approximately 5% of the 46,154,188 common shares currently outstanding and trading. The company’s CEO, Jennifer Bath, stated, “With a significantly strengthened balance sheet and a marked improvement in our financial position, we believe it is appropriate to add a share repurchase program to our long-term capital allocation strategy. There have been periods when our share price has deviated notably from what we believe to be its intrinsic value. This authorization gives us the flexibility to repurchase shares when it represents the best use of capital and serves the best interests of our shareholders.” Any share repurchases under the program, if undertaken, may be conducted from time to time in the open market at prevailing market prices, through privately negotiated transactions, or by other legally permissible means, depending on market conditions and compliance with applicable rules and regulations. The purchase price for the common shares will be determined in accordance with applicable U.S. securities laws, and the consideration offered per share will not exceed the market price of the common shares calculated under applicable Canadian securities regulations. The timing, volume, and terms of repurchases will be at the discretion of the company. All purchases will be subject to general market conditions, the company’s capital management strategy, other investment opportunities, regulatory requirements, and other factors. The program does not obligate the company to repurchase any specific number of shares. The company currently intends to fund the program using its existing cash and cash equivalents, short-term investments, future cash flows, and/or financing activities. The board will periodically review the program and may adjust its terms, scope, or suspend or terminate it at any time without prior notice. Repurchased shares may be held by the company as treasury shares or retired shares and may be used for future corporate purposes, including equity compensation or other strategic initiatives. About MindWalk MindWalk is a bio-native AI company transforming drug discovery and development. Leveraging its proprietary HYFT® technology and the LensAI™ platform, MindWalk unifies biological sequences, structures, functions, and scientific literature into a single computational language. The platform enables rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biological analysis, accelerating the translation of scientific knowledge into validated drug candidates through an integrated wet-lab system. Forward-Looking Statements This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. These statements include, among others, statements regarding the share repurchase program (including its size, timing, terms, duration, and potential effects), expected sources and uses of cash, capital allocation priorities, the board’s and management’s intentions and discretion regarding repurchases, and the company’s commercial outlook and growth plans. Words such as “may,” “will,” “could,” “should,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “targets,” “seeks,” “potential,” “continues,” and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. These risks include, but are not limited to: volatility in the company’s share price and general market conditions; the ability to conduct repurchases in compliance with applicable legal and regulatory requirements (including Rule 10b-18, stock exchange rules, and blackout periods); the company’s financial performance, cash flow, liquidity, and capital needs; alternative uses of capital, such as growth investments, acquisitions, or debt reduction; limitations in broker capacity, average daily trading volume, and execution pricing; fluctuations in foreign exchange rates; tax, legal, or accounting considerations; changes in laws, regulations, listing requirements, or their interpretation; and other risk factors detailed in the company’s filings with the U.S. Securities and Exchange Commission and Canadian securities regulators, including its annual report on Form 20-F for the fiscal year ended April 30, 2025, and subsequent reports. The share repurchase program is discretionary. It does not obligate the company to repurchase any specific number of shares and may be modified, suspended, or terminated at any time without notice. Forward-looking statements are made only as of the date of this press release and the company undertakes no obligation to update or revise them, except as required by applicable law. The translated version of this press release should not be considered official. The original version in English is the only authoritative version. The translated text must always be compared to the source document, which prevails.